Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 5,900 shares at $133.31 ($784K) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Scheduled sale ($784k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $132.45 | 1,574 | $208K | 26.6% |
| 2 | $132.45 | 1,574 | $208K | 26.6% |
| 3 | $133.31 | 1,326 | $177K | 22.5% |
| 4 | $133.31 | 1,326 | $177K | 22.5% |
| 5 | $134.08 | 100 | $13K | 1.7% |
| Total | $132.86 avg | 5,900 |
| $784K |
| 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |